Helicobacter pylori Treatment and Central Serous Chorioretinopathy
Author Information
Author(s): Rahbani-Nobar Mohammad Bagher, Javadzadeh Alireza, Ghojazadeh Leila, Rafeey Mandana, Ghorbanihaghjo Amir
Primary Institution: Tabriz University of Medical Sciences
Hypothesis
Does Helicobacter pylori treatment affect the remission of idiopathic central serous chorioretinopathy?
Conclusion
Anti-H. pylori treatment can lead to faster reabsorption of subretinal fluid in patients with idiopathic central serous chorioretinopathy.
Supporting Evidence
- Subretinal fluid reabsorption time was significantly shorter in the treatment group.
- All patients in the treatment group responded to the H. pylori eradication treatment.
- No systemic adverse effects of medication were observed.
Takeaway
This study found that treating a stomach bug called H. pylori can help people with a specific eye problem get better faster.
Methodology
A randomized controlled trial with 50 patients divided into treatment and control groups, measuring visual acuity and subretinal fluid over 16 weeks.
Limitations
The study had a small sample size and short follow-up period.
Participant Demographics
Mean age was 32.54 years in the treatment group and 34.24 years in the control group, with a male to female ratio of approximately 4:1.
Statistical Information
P-Value
0.015
Statistical Significance
p=0.015
Want to read the original?
Access the complete publication on the publisher's website